# Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations

> **NCT00831350** · PHASE2 · COMPLETED · sponsor: **Barnes Retina Institute** · enrollment: 32 (actual)

## Conditions studied

- Retinal Vein Occlusion
- Posterior Vitreous Detachment

## Interventions

- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT00831350
- **Lead sponsor:** Barnes Retina Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-07
- **Final completion:** 2012-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00831350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00831350, "Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00831350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*